Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Aileron Therapeutics Inc. logo

Aileron Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

3.21
 
USD
  
-0.01
  
(-0.31%)
Optionable: No  Market Cap: 70 M  90-day average vol: 99,884

Previous close: 3.22  Open: 3.34  Bid: 1.29  Ask: 3.51
52 week range    
1.01   
   7.42
Last updated: Tuesday 18th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ALRN Income Statement

Annual
Invalid dateDec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccretionOnPreferredStock41000.0
Basic EPS from continuing operations-12.2-5.8-6.02
Basic EPS total-12.2-5.8-6.02
Basic weighted shares outstanding372153.0736909.01 M2 M4 M5 M
Depreciation-129000.0-218000.0-140000.0163000.0121000.0169000.0
DepreciationAndAmortization-129000.0-218000.0-140000.0163000.0121000.0169000.0
Diluted EPS total-60.8-42.8-24.0-12.2-5.8-6.02
Diluted normalized net income/share-24.0-6.02
Diluted weighted shares outstanding371776.0737079.01 M2 M5 M
GainOnSaleOfPPE-5000.086000.066000.0
GeneralAndAdministrativeExpense9 M13 M12 M9 M10 M10 M
Income before tax-23 M-32 M-29 M-21 M-26 M-27 M
Income restructuring and M&A52 M
Interest income404000.0355000.0587000.0
MiscOtherSpecialCharges587000.0-661000.0441000.0318000.0
Net income from total operations-23 M-32 M-29 M-21 M-26 M-27 M
NetIncomeCommonStockholders-23 M-32 M-29 M-21 M-26 M-27 M
NetIncomeContinuousOperations-23 M-32 M-29 M-21 M-26 M-27 M
NetIncomeDiscontinuousOperations210000.0929000.0749000.0
NetNonOperatingInterestIncomeExpense404000.0355000.0587000.0
Operating income-23 M-32 M-30 M-20 M-27 M-28 M
Operating income before depreciation (EBITDA)-23 M-32 M-29 M-21 M-26 M-27 M
OperatingExpense-23 M-32 M30 M20 M27 M28 M
Other income net-587000.0661000.0-441000.0-318000.0
OtherGandA9 M13 M12 M9 M10 M10 M
OtherOperatingExpenses-23 M-32 M-30 M1 M93000.0125000.0
OtherunderPreferredStockDividend41000.0
PreferredStockDividends41000.0
ProvisionForGainLossOnDisposal210000.0929000.0749000.0
RentAndLandingFees9 M13 M
Research & development expense14 M18 M18 M11 M17 M18 M
ResearchExpense14 M18 M18 M11 M17 M18 M
RestructringAndMnAIncome52 M
SalariesAndWages-2 M-3 M-2 M
Selling Gen & administrative expense9 M13 M12 M9 M10 M10 M
Special income/charges-52 M
Total Income available for interest expense (EBIT)-23 M-32 M-29 M-21 M-26 M-27 M
Total common shares outstanding736719.0743751.01 M5 M5 M5 M
Total net income-23 M-32 M-29 M-21 M-26 M-27 M
Total ordinary shares22 M22 M22 M22 M22 M22 M
TotalExpenses-23 M-32 M30 M20 M27 M28 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University